BIOMAT Database Logo BIOMAT Database Logo

Opportunities for targeting publicly funded human immunodeficiency virus counseling and testing. 1996

T A Peterman, and K A Todd, and I Mupanduki
Division of STD/HIV Prevention, National Center for Prevention Services, Centers for Disease Control and Prevention, Atlanta, Georgia, 30333, USA.

We wished to identify opportunities for improving the yield of positive HIV test results from federally funded HIV counseling and testing programs. We reviewed client records from 1992 and 1993 for targeting opportunities at the site level based on site type (i.e., family planning clinic) and the seropositivity in the past and at the client level based on the client's history of a past negative test, demographics, and risk history. We studied 1,281,606 records from 1992. The number of tests and opportunities for site-level targeting varied by project area. Seropositivity varied by site type, but the best predictor of seropositivity was seropositivity at that site in the past. Of 1,102 sites with <1% of tests positive in 1992, only five had >3% positive in 1993. Sites with no positive tests in 1992 performed 99,468 tests in 1993, and only 292 (0.3%) were positive. Clients with a past negative test had a slightly lower seropositivity (1.5%) than clients with no previous test (2.0%). In sites with a low (0.1-2.0%) seropositivity, clients with no transmission risk by history were unlikely to be infected (0.8% for black men). However, in sites with high (> or =5%) seropositivity, clients without risk were often infected (5.7% for black men). Opportunities for targeting were identified. They vary considerably by project area and testing site. These opportunities for targeting should be considered by sites as AIDS prevention strategies evolve.

UI MeSH Term Description Entries
D008297 Male Males
D002487 Centers for Disease Control and Prevention, U.S. An agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries. United States Centers for Disease Control and Prevention,CDC,CDCP,Center for Disease Control,Center for Disease Control and Prevention,Centers for Disease Control,Centers for Disease Control (U.S.),Centers for Disease Control and Prevention,Centers for Disease Control and Prevention (U.S.),Centers for Disease Control, U.S.,United States Centers for Disease Control
D003376 Counseling The giving of advice and assistance to individuals with educational or personal problems.
D005260 Female Females
D005380 Financing, Government Federal, state, or local government organized methods of financial assistance. Federal Aid,Financing, Public,Grants and Subsidies, Government,Hill-Burton Act,Subsidies, Government,Government Financing,Act, Hill-Burton,Aid, Federal,Aids, Federal,Federal Aids,Government Subsidies,Government Subsidy,Hill Burton Act,Public Financing,Subsidy, Government
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.

Related Publications

T A Peterman, and K A Todd, and I Mupanduki
Publicly funded HIV counseling and testing--United States, 1991.
August 1992, MMWR. Morbidity and mortality weekly report,
T A Peterman, and K A Todd, and I Mupanduki
Publicly funded HIV counseling and testing--United States, 1990.
October 1991, MMWR. Morbidity and mortality weekly report,
T A Peterman, and K A Todd, and I Mupanduki
Publicly funded HIV counseling and testing--United States, 1990.
April 1992, Patient education and counseling,
T A Peterman, and K A Todd, and I Mupanduki
Publicly funded HIV counseling and testing--United States, 1985-1989.
March 1990, MMWR. Morbidity and mortality weekly report,
T A Peterman, and K A Todd, and I Mupanduki
Publicly funded HIV counseling and testing--United States, 1985-1989.
August 1990, Patient education and counseling,
T A Peterman, and K A Todd, and I Mupanduki
Counseling and testing for the human immunodeficiency virus.
February 1987, Minnesota medicine,
T A Peterman, and K A Todd, and I Mupanduki
HIV incidence among women who seek publicly funded counseling, testing.
May 1991, The Journal of the American Osteopathic Association,
T A Peterman, and K A Todd, and I Mupanduki
Human immunodeficiency virus antibody testing and counseling.
January 1988, North Carolina medical journal,
T A Peterman, and K A Todd, and I Mupanduki
Publicly funded HIV counseling and testing in the United States, 1992-1995.
June 1997, AIDS education and prevention : official publication of the International Society for AIDS Education,
T A Peterman, and K A Todd, and I Mupanduki
From the Centers for Disease Control. Publicly funded HIV counseling and testing--United States, 1991.
January 1992, JAMA,
Copied contents to your clipboard!